Logo Image
|Articles|May 15, 2020

Pharmaceutical Technology

  • Pharmaceutical Technology-05-15-2020
  • Volume 2020 eBook
  • Issue 2

Considerations in Contamination Control

Author(s)Susan Haigney

A contamination control strategy can prevent contamination in sterile product manufacturing. The right system, equipment, and personnel training are also essential to mitigate risk.

Pharmaceutical Technology spoke with Richard Denk, senior consultant aseptic processing and containment, SKAN AG, about the risks of contamination in biopharmaceutical manufacturing and how this risk can be mitigated.

Read this article in Pharmaceutical Technology Biologics and Sterile Drug Manufacturing May 2020 eBook.

Article Details

Pharmaceutical Technology
eBook: Biologics and Sterile Drug Manufacturing, May 2020
May 2020
Pages: 38–42

Citation

When referring to this article, please cite it as S. Haigney, “Considerations in Contamination Control," Pharmaceutical Technology Biologics and Sterile Drug Manufacturing eBook (May 2020).

 

Articles in this issue

about 6 years ago

On Point: Biologics Drive Growth in Pre-Filled Syringes

about 6 years ago

Instrumenting Single-Use Processes

about 6 years ago

Best systems and equipment for contamination control

about 6 years ago

Building Data Quality In Generates Quality Data Out

about 6 years ago

Detecting Contamination in Cell Therapies

about 6 years ago

Optimizing Viral Vector Manufacturing for Gene Therapy

about 6 years ago

Minimizing Contamination During Biopharma R&D

about 6 years ago

Complications in Process Simulation Execution

Related Content